&nbsp;

GoalsOfCarePoster-FR.pdf

Oct 2021

Document

GOC-DocumentationTemplate-FR.pdf

Oct 2021

Document

GOC-DocumentationTemplate.pdf

Oct 2021

Drug

gemtuzumab ozogamicin

Other Name(s): Mylotarg®

Quick Link(s): Drug Monograph, Patient Info Sheet

Jun 2022

Regimen

GILT

Cancer Type:

Hematologic,

Leukemia - Acute Myeloid (AML)

Intent: Palliative

Funding:

Exceptional Access Program

gilteritinib - Relapsed or Refractory FLT3-mutated acute myeloid leukemia

Drugs Used:

gilteritinib

Quick Link(s):

Regimen Monograph

Mar 2022

Drug

gilteritinib

Other Name(s): Xospata®

Quick Link(s): Drug Monograph, Patient Info Sheet

Jul 2023

Regimen

GDCRBP+RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Curative

Funding:

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Aggressive Histology Lymphoma

ODB - General Benefit

dexamethasone

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Aggressive Histology Lymphoma

Drugs Used:

Quick Link(s):

Regimen Monograph

Jan 2024

Document

treemapDesignPage3.html

Apr 2022

Regimen

TRAM

Cancer Type:

Gynecologic,

Ovary

Intent: Palliative

Drugs Used:

trametinib (Unfunded)

Quick Link(s):

Regimen Monograph

May 2022

Regimen

TAFA(MNT)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Intermediate Grade

Intent: Palliative

Drugs Used:

tafasitamab (Unfunded)

Quick Link(s):

Regimen Monograph

Jul 2023

Regimen

TRAS(MNT)

Cancer Type:

Head and Neck,

Salivary Gland

Intent: Palliative

Drugs Used:

trastuzumab (Unfunded)